CIK 0000908259 · Non-accelerated filer<br>Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133679168
- Phone
- 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- 4 Open-market buy CHAIRMAN AND CEO bought 70,000 shares at $0.08 ($5,600)
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 4 Open-market buy CHAIRMAN AND CEO bought 20,000 shares at $0.07 ($1,360)
- 4 Open-market buy CHAIRMAN AND CEO bought 80,000 shares at $0.08 ($6,560)
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 8-K Event Executive or director change
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Other events
Page 6 of 61 · 1,218 filings